Compare ONL & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONL | BDSX |
|---|---|---|
| Founded | 2021 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Precision Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.4M | 153.3M |
| IPO Year | 2021 | 2020 |
| Metric | ONL | BDSX |
|---|---|---|
| Price | $2.75 | $21.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $3.00 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 627.1K | 92.2K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.83% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $147,647,000.00 | $88,499,000.00 |
| Revenue This Year | $4.10 | $25.26 |
| Revenue Next Year | $3.10 | $19.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 24.08 |
| 52 Week Low | $1.92 | $0.29 |
| 52 Week High | $3.04 | $24.92 |
| Indicator | ONL | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 44.45 | 60.37 |
| Support Level | $2.62 | $6.63 |
| Resistance Level | $2.98 | $24.92 |
| Average True Range (ATR) | 0.11 | 2.38 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 40.26 | 63.67 |
Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.